Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis
- 1 January 2000
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 105 (1), 58-64
- https://doi.org/10.1016/s0091-6749(00)90178-7
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.Thorax, 1998
- High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.Journal of Clinical Investigation, 1997
- Allergic rhinitis and inflammation: the effect of nasal corticosteroid therapyAllergy, 1997
- Molecular Cloning of Human Eotaxin, an Eosinophil-selective CC Chemokine, and Identification of a Specific Eosinophil Eotaxin Receptor, CC Chemokine Receptor 3Published by Elsevier ,1996
- Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.Journal of Clinical Investigation, 1996
- Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndromeEuropean Respiratory Journal, 1994
- Oxidative Stress Induces NFκB DNA Binding and Inducible NOS mRNA in Human Epithelial CellsBiochemical and Biophysical Research Communications, 1994
- Autoinhalation of nitric oxide after endogenous synthesis in nasopharynxThe Lancet, 1994
- The Chemokine, Eotaxin, Activates Guinea-Pig Eosinophils in Vitro and Causes Their Accumulation into the Lung in VivoBiochemical and Biophysical Research Communications, 1993
- Nitric oxide and lung disease.Thorax, 1993